GT Biopharma, Inc.
Current role
GTBP
Dr. Jeffrey Miller
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Dr. Jeffrey Miller
GT Biopharma, Inc. reported in an 8-K filed September 16, 2024 that Dr. Jeffrey Miller was appointed Consulting Senior Medical Director, effective September 16, 2024.
“Effective September 16, 2024, Dr. Jeffrey Miller ceased serving as the Registrant's Consulting Chief Medical Officer and Consulting Chief Scientific Officer and commenced service as the Registrant's Consulting Senior Medical Director.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
GT Biopharma, Inc. (GTBP)
SEC 8-K
Current2024-09-16–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at GT Biopharma, Inc.
Other people whose current roles at this company are on record from its filings.
- Anthony Cataldo CEO
- Dr. Gregory Berk CEO
- Michael Breen CEO, Board Member
- Bruce Wendel Chairman
- Alan L. Urban CFO, Board Member
- Alan Urban CFO
- Dr. Gavin Choy CFO
- Michael Handelman CFO
- Andrew Ritter Board Member
- Charles J. Casamento Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.